Ganirelix Acetate
- Product NDC
- 65219-028
- 11-digit product format
- 652190028
- Labeler code
- 65219
- Product ID
- 65219-028_8b68715d-8b5a-473f-90fb-453ba4267b84
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ganirelix Acetate
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA215658
- Marketing category
- ANDA
- Marketing start
- 2023-03-24
- Substance
- GANIRELIX ACETATE
- Active strength
- 250 ug/.5mL
- Pharmacologic classes
- Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ganirelix Acetate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GANIRELIX ACETATE | 250 ug/.5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 56U7906FQW |
| Rxcui | 855200 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 65219-028-05 | Ganirelix Acetate | 1 mL in 1 SYRINGE, GLASS | INJECTION | 1 | | 2 |
| 65219-028-05 | Ganirelix Acetate | 1 in 1 CARTON | INJECTION | 1 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65219-028 | GANIRELIX ACETATE INJECTION [FRESENIUS KABI USA, LLC] | 2 | Current NDC, 2 package rows | 20240530_c23ca7b2-7350-4f07-8adf-046bffb47842.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 65219-028-05 | 65219002805 | 1 SYRINGE, GLASS in 1 CARTON (65219-028-05) / 1 mL in 1 SYRINGE, GLASS | 2023-03-24 | No | No | Current |